CompoAtlas

Contralenta

Natural health product licensed in Canada

Licence holder
Immunotec Inc.
NPN or DIN-HM
80057247
Status
Active licence
Licence date
13 January 2015
Revision date
19 October 2022
Form
Comprimé, enrobé par pellicule
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Harpagophytum procumbens

Source : Racine

16.66 milligrammeNot calculated
Harpagophytum procumbens

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 66.64 milligramme

Not specifiedNot calculated
Sulfate de chondroïtine

Source : Chondroïtin sulfate de sodium

50 milligrammeNot calculated
Sulfate de 2-amino-2-désoxy-D-glucose

Source : Sulfate de glucosamine chlorure de potassium

500 milligrammeNot calculated
Méthylsulfonylméthane

Source : Sulfone de diméthyl

333.33 milligrammeNot calculated
Boswellia serrata

Source : Oléorésine

16.66 milligrammeNot calculated
Boswellia serrata

Source : Oléorésine

40 %Not calculated
Boswellia serrata

Source : Oléorésine

Extract : Matériel brut sec

Extraction ratio : 5:1

Dry plant equivalent : 83.3 milligramme

Not specifiedNot calculated
Boswellia serrata

Source : Oléorésine

Potency : 30 % Eau Purifiée

Not specifiedNot calculated
Boswellia serrata

Source : Oléorésine

Potency : 70 % éthanol

Not specifiedNot calculated
Bore

Source : Citrate de bore

0.166 milligrammeNot calculated

Non-medicinal ingredients

Hypromellose, Glycérine, Cellulose, microcristalline, Croscarmellose de sodium, Phosphate de calcium, dibasique, Hydroxypropylcellulose, Acide stéarique, Maltodextrine, Dioxyde de silicium

PopulationAgeQuantity per servingFrequency
AdultesNot specified3 Comprimé1 day

Uses authorised in Canada

Aide à soulager les douleurs articulaires associées a l'arthrose (du genou). Aide à protéger contre la détérioration du cartilage. Contribue au maintien du cartilage sain et/ou d'articulations saines. Le bore aide à maintenir un métabolisme du calcium sain.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80057247

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2022. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line